Vanda Marković‐Peković

2.3k total citations
27 papers, 458 citations indexed

About

Vanda Marković‐Peković is a scholar working on Applied Microbiology and Biotechnology, Geriatrics and Gerontology and Economics and Econometrics. According to data from OpenAlex, Vanda Marković‐Peković has authored 27 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Applied Microbiology and Biotechnology, 13 papers in Geriatrics and Gerontology and 10 papers in Economics and Econometrics. Recurrent topics in Vanda Marković‐Peković's work include Antibiotic Use and Resistance (14 papers), Pharmaceutical Practices and Patient Outcomes (13 papers) and Pharmaceutical Economics and Policy (8 papers). Vanda Marković‐Peković is often cited by papers focused on Antibiotic Use and Resistance (14 papers), Pharmaceutical Practices and Patient Outcomes (13 papers) and Pharmaceutical Economics and Policy (8 papers). Vanda Marković‐Peković collaborates with scholars based in Bosnia and Herzegovina, United Kingdom and South Africa. Vanda Marković‐Peković's co-authors include Brian Godman, Ranko Škrbić, Johanita R. Burger, Iris Hoxha, Lars L. Gustafsson, Margaret Oluka, Admir Malaj, Silvia Bino, Joseph Fadare and Jurij Fürst and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Pharmacology and European Journal of Clinical Pharmacology.

In The Last Decade

Vanda Marković‐Peković

23 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vanda Marković‐Peković Bosnia and Herzegovina 11 274 116 115 98 82 27 458
Anahí Dreser Mexico 13 258 0.9× 102 0.9× 120 1.0× 79 0.8× 95 1.2× 36 542
Caijun Yang China 14 274 1.0× 110 0.9× 161 1.4× 105 1.1× 81 1.0× 36 510
Muhammad Majid Aziz China 12 264 1.0× 154 1.3× 65 0.6× 137 1.4× 67 0.8× 32 521
Ali Hassan Gillani China 14 240 0.9× 126 1.1× 146 1.3× 125 1.3× 68 0.8× 40 628
Sylvia Opanga Kenya 11 202 0.7× 66 0.6× 63 0.5× 106 1.1× 82 1.0× 30 433
Faiz Ullah Khan China 15 227 0.8× 117 1.0× 59 0.5× 123 1.3× 67 0.8× 71 498
Olayinka O. Ogunleye Nigeria 19 282 1.0× 139 1.2× 111 1.0× 99 1.0× 149 1.8× 43 738
Iram Malik Pakistan 13 210 0.8× 151 1.3× 116 1.0× 119 1.2× 77 0.9× 27 504
Barry Strickland–Hodge United Kingdom 10 240 0.9× 163 1.4× 62 0.5× 82 0.8× 79 1.0× 27 434
Israel Abebrese Sefah Ghana 14 315 1.1× 79 0.7× 51 0.4× 109 1.1× 76 0.9× 38 457

Countries citing papers authored by Vanda Marković‐Peković

Since Specialization
Citations

This map shows the geographic impact of Vanda Marković‐Peković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanda Marković‐Peković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanda Marković‐Peković more than expected).

Fields of papers citing papers by Vanda Marković‐Peković

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanda Marković‐Peković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanda Marković‐Peković. The network helps show where Vanda Marković‐Peković may publish in the future.

Co-authorship network of co-authors of Vanda Marković‐Peković

This figure shows the co-authorship network connecting the top 25 collaborators of Vanda Marković‐Peković. A scholar is included among the top collaborators of Vanda Marković‐Peković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanda Marković‐Peković. Vanda Marković‐Peković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Campbell, Stephen, Vanda Marković‐Peković, Natalie Schellack, et al.. (2024). Potential Strategies to Limit Inappropriate Purchasing of Antibiotics without a Prescription in a Rural Province in South Africa: Pilot Study and the Implications. SHILAP Revista de lepidopterología. 14(1). 60–67. 11 indexed citations
3.
Škrbić, Ranko, et al.. (2023). Eleven-Year Trends in Lipid-Modifying Medicines Utilisation and Expenditure in a Low-Income Country: A Study from the Republic of Srpska, Bosnia and Herzegovina. ClinicoEconomics and Outcomes Research. Volume 15. 513–523. 2 indexed citations
4.
Marković‐Peković, Vanda, et al.. (2023). Effective Programmes to Reduce Inappropriate Dispensing of Antibiotics in Community Pharmacies Especially in Developing Countries. SHILAP Revista de lepidopterología. 8 indexed citations
5.
Škrbić, Ranko, Duško Vulić, Miloš P. Stojiljković, et al.. (2022). Trends in Antihypertensive Medicine Utilization in the Republic of Srpska, Bosnia and Herzegovina: An Eleven-Year Follow-Up. Frontiers in Pharmacology. 13. 889047–889047. 4 indexed citations
6.
Wettermark, Björn, Amanj Kurdi, Caridad Pontes, et al.. (2022). Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries. Frontiers in Pharmacology. 13. 873556–873556. 9 indexed citations
7.
Saleem, Zikria, Brian Godman, Aubrey Chichonyi Kalungia, et al.. (2021). Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications. Expert Review of Anti-infective Therapy. 20(1). 71–93. 63 indexed citations
8.
Marković‐Peković, Vanda, et al.. (2021). Availability and accessibility of monoclonal antibodies in Bosnia and Herzegovina: Findings and implications. SHILAP Revista de lepidopterología. 5. 3888122604–3888122604. 8 indexed citations
9.
Godman, Brian, Joseph Fadare, Hye-Young Kwon, et al.. (2021). Evidence-based public policy making for medicines across countries: findings and implications for the future. Journal of Comparative Effectiveness Research. 10(12). 1019–1052. 32 indexed citations
10.
Marković‐Peković, Vanda. (2020). The first modern pharmacy in Banja Luka: The Brammer family, three generations of pharmacists. Scripta Medica. 51(4). 284–291.
11.
Hoxha, Iris, Admir Malaj, Silvia Bino, et al.. (2018). Are pharmacists’ good knowledge and awareness on antibiotics taken for granted? The situation in Albania and future implications across countries. Journal of Global Antimicrobial Resistance. 13. 240–245. 53 indexed citations
12.
Marković‐Peković, Vanda, et al.. (2018). Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications. Frontiers in Pharmacology. 9. 442–442. 32 indexed citations
13.
Marković‐Peković, Vanda, et al.. (2017). Initiatives to reduce non-prescription sales and dispensing of antibiotics in the Republic of Srpska : findings and implications. Journal of Research in Pharmacy Practice. 1 indexed citations
14.
Bochenek, Tomasz, Anna Bucsics, Elfi De Weerdt, et al.. (2016). Systemic Solutions, Legislative And Organizational Frameworks Aimed To Prevent Or Mitigate Drug Shortages In European Countries. Value in Health. 19(7). A445–A445. 1 indexed citations
15.
Marković‐Peković, Vanda & Ranko Škrbić. (2016). Long-term drug use and polypharmacy among the elderly population in the Republic of Srpska, Bosnia and Herzegovina. Vojnosanitetski pregled. 73(5). 435–441. 1 indexed citations
16.
Marković‐Peković, Vanda, Ranko Škrbić, Aleksandar Petrović, et al.. (2015). Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future. Expert Review of Pharmacoeconomics & Outcomes Research. 16(5). 609–618. 15 indexed citations
17.
Marković‐Peković, Vanda, Ranko Škrbić, Brian Godman, & Lars L. Gustafsson. (2012). Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions. Expert Review of Pharmacoeconomics & Outcomes Research. 12(5). 661–671. 31 indexed citations
18.
Godman, Brian, Marion Bennie, Christoph Baumgärtel, et al.. (2012). Essential to increase the use of generics in Europe to maintain comprehensive health care?. SHILAP Revista de lepidopterología. 13(3S). 5–20. 33 indexed citations
19.
Marković‐Peković, Vanda, et al.. (2009). Outpatient utilization of drugs acting on nervous system: a study from the Republic of Srpska, Bosnia & Herzegovina. European Journal of Clinical Pharmacology. 66(2). 177–186. 9 indexed citations
20.
Marković‐Peković, Vanda, et al.. (2009). Utilisation of cardiovascular medicines in Republic of Srpska, Bosnia and Herzegovina, 5 years study. Pharmacoepidemiology and Drug Safety. 18(4). 320–326. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anahí Dreser Breakdown of academic impact, for papers by Caijun Yang Breakdown of academic impact, for papers by Muhammad Majid Aziz Breakdown of academic impact, for papers by Ali Hassan Gillani Breakdown of academic impact, for papers by Sylvia Opanga Breakdown of academic impact, for papers by Faiz Ullah Khan Breakdown of academic impact, for papers by Olayinka O. Ogunleye Breakdown of academic impact, for papers by Iram Malik Breakdown of academic impact, for papers by Barry Strickland–Hodge Breakdown of academic impact, for papers by Israel Abebrese Sefah
Rankless by CCL
2026